Rosenblatt Securities Reaffirms “Buy” Rating for Quantinuum (NASDAQ:QNT)

Quantinuum (NASDAQ:QNT)‘s stock had its “buy” rating reissued by equities researchers at Rosenblatt Securities in a report released on Wednesday,Benzinga reports. They presently have a $155.00 price target on the stock. Rosenblatt Securities’ price target suggests a potential upside of 176.49% from the company’s current price.

Several other equities research analysts have also weighed in on QNT. JPMorgan Chase & Co. initiated coverage on shares of Quantinuum in a report on Monday, June 29th. They issued an “overweight” rating and a $97.00 target price on the stock. Sanford C. Bernstein initiated coverage on shares of Quantinuum in a report on Monday, June 29th. They set an “outperform” rating and a $94.00 price target for the company. Jefferies Financial Group set a $85.00 price objective on shares of Quantinuum in a research note on Wednesday. Morgan Stanley started coverage on shares of Quantinuum in a research note on Monday, June 29th. They issued an “equal weight” rating and a $78.00 target price for the company. Finally, UBS Group assumed coverage on Quantinuum in a research report on Monday, June 29th. They set a “buy” rating and a $93.00 price target on the stock. Twelve equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Quantinuum currently has an average rating of “Moderate Buy” and a consensus price target of $98.33.

Quantinuum Stock Down 0.9%

Shares of QNT opened at $56.06 on Wednesday. Quantinuum has a 1 year low of $47.06 and a 1 year high of $86.79. The stock has a 50 day moving average of $62.71.

Quantinuum (NASDAQ:QNT) last announced its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The business had revenue of $8.00 million during the quarter. As a group, equities research analysts expect that Quantinuum will post -1.61 earnings per share for the current year.

Insider Activity at Quantinuum

In related news, Director Hal Barron purchased 250,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were acquired at an average cost of $60.00 per share, with a total value of $15,000,000.00. Following the completion of the purchase, the director directly owned 255,833 shares of the company’s stock, valued at $15,349,980. This trade represents a 4,285.96% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Manish H. Bhatia acquired 20,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The stock was bought at an average price of $60.00 per share, with a total value of $1,200,000.00. Following the transaction, the director directly owned 25,833 shares in the company, valued at $1,549,980. The trade was a 342.88% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 411,032 shares of company stock valued at $24,661,920 in the last three months.

Hedge Funds Weigh In On Quantinuum

An institutional investor recently bought a new stake in Quantinuum stock. Lisanti Capital Growth LLC purchased a new stake in Quantinuum Inc. (NASDAQ:QNT) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 5,005 shares of the company’s stock, valued at approximately $409,000.

Key Headlines Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum reported second-quarter revenue of $8 million, a 279% year-over-year increase, and raised its fiscal 2026 revenue outlook to $28 million-$32 million versus the $26.6 million analyst consensus. Quantinuum Reports Second Quarter 2026 Results
• Positive Sentiment: Quantinuum announced a multiyear partnership with Oracle (NYSE: ORCL) to deploy its 98-qubit Helios system in a U.S.-based Oracle Cloud Infrastructure AI data center. Customers will be able to access hybrid quantum-AI and high-performance computing capabilities through Oracle Cloud without owning specialized quantum hardware, potentially accelerating commercial adoption. Oracle, Quantinuum partner to bring quantum computing to cloud
• Positive Sentiment: The company said Helios demonstrated near five-nines logical fidelity, reinforcing Quantinuum’s positioning in fault-tolerant quantum computing. The Oracle deployment could provide an important bridge from technical milestones to applications such as drug discovery, materials science, financial modeling and optimization. Quantinuum Puts a 98-Qubit Helios Machine Inside Oracle’s AI Data Centers
• Negative Sentiment: Quantinuum reported an adjusted loss of $0.28 per share, slightly worse than the $0.26 consensus estimate. The earnings shortfall and the company’s still-small revenue base appear to have outweighed the favorable outlook and strategic partnership, helping explain why the stock finished lower. Quantinuum Reports Second Quarter 2026 Results

About Quantinuum

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.